Vergleich

Mumps IgG ELISA Kit

ArtNr DEIA363
Hersteller Creative Diagnostics
Menge 96T
Kategorie
Typ Elisa-Kit
Specific against other
ECLASS 10.1 32160605
ECLASS 11.0 32160605
UNSPSC 41116126
Lieferbar
Full name
Mumps virus
Intended Use
in-vitro diagnostic, The MumpsIgG Antibody ELISA Test Kit has been designed for the the detection and thequantitative determination of specific IgG antibodies against Mumps virus in serumand plasma. Further applications in other body fluids are possible and can berequested from the Technical Service. This assay is intended for in-vitrodiagnostic use only. Laboratory results can never be the only base of amedical report. The patient history and further tests have additionally to betaken into account.
Principle Of The Test
The Mumps IgGantibody test kit is based on the principle of the enzyme immunoassay (EIA).Mumps antigen is bound on the surface of the microtiter strips. Dilutedpatient serum or ready-to-use standards are pipetted into the wells of themicrotiter plate. A binding between the IgG antibodies of the serum and the immobilizedMumps antigen takes place. After a one hour incubation at room temperature, the plate is rinsed with diluted wash solution, in order to remove unboundmaterial. Then ready-to-use anti-human-IgG peroxidase conjugate is added and incubatedfor 30 minutes. After a further washing step, the substrate (TMB) solution ispipetted and incubated for 20 minutes, inducing the development of a blue dyein the wells. The color development is terminated by the addition of a stop solution, which changes the color from blue to yellow. The resulting dye is measuredspectrophotometrically at the wavelength of 450 nm. The concentration of theIgG antibodies is directly proportional to the intensity of the color.
Reagents And Materials Provided
Store kitcomponents at 2-8C and do not use after the expiry date on thebox outer label. Before use, all components should be allowed to warm up toambient temperature (18-25oC). After use, the plate should beresealed, the bottle caps replaced and tightened and the kit stored at 2-8oC.The opened kit should be used within three months. MikrotiterStrips: 12strips with 8 breakable wells each, coated with a Mumps antigen (StrainEnders, ATCC VR-106). Ready-to-use. Cut-Off Standard:2mL human serum diluted with PBS, contains a low concentration of IgGantibodies against Mumps. Addition of 0.01 % methylisothiazolone and 0.01 %bromonitrodioxane. Ready-to-use. WeakPositive Control: 2 mL, human serum diluted with PBS, containsa medium concentration of IgG antibodies against Mumps. Addition of 0.01 %methylisothiazolone and 0.01 % bromonitrodioxane. Ready-to-use. PositiveControl: 2mL, human serum diluted with PBS, contains a high concentration of IgGantibodies against Mumps. Addition of 0.01 % methylisothiazolone and 0.01 %bromonitrodioxane. Ready-to-use. NegativeControl: 2mL, protein solution diluted with PBS, contains no IgG antibodies againstMumps. Addition of 0.01 % methylisothiazolone and 0.01 % bromonitrodioxane.Ready-to-use. EnzymeConjugate: 15 mL, anti-human-IgG-HRP (rabbit), inprotein-containing buffer solution. Addition of 0.01 % methylisothiazoloneand 0.01 % bromonitrodioxane and 5 mg/L ProclinTM. Ready-to-use. Substrate:15mL, TMB (tetramethylbenzidine). Ready-to-use. StopSolution: 15 mL, 0.5 M sulfuric acid. Ready-to-use. SampleDiluent: 60mL, PBS/BSA buffer. Addition of 0.095 % sodium azide. Ready-to-use. WashingBuffer: 60mL, PBS + Tween 20, 10x concentrate. Final concentration: dilute 1+9 withdistilled water. If during the cold storage crystals precipitate, theconcentrate should be warmed up at 37C for 15 minutes. PlasticFoils: 2pieces to cover the microtiter strips during the incubation. PlasticBag: Resealable, for the dry storage of non-used strips.
Materials Required But Not Supplied
1. 5 uL-, 100 uL-and 500 uL micro- and multichannel pipets 2. Microtiter PlateReader (450 nm) 3. Microtiter PlateWasher 4. Reagent tubes forthe serum dilution 5. Bidistilled water
Specimen Collection And Handling
Principally serum orplasma (EDTA, heparin) can be used for the determination. Serum is separated fromthe blood, which is aseptically drawn by venipuncture, after clotting andcentrifugation. The serum or plasma samples can be stored refrigerated(2-8oC) for up to 48 hours, for a longer storage they should be kept at -20oC. The samples should not be frozen and thawed repeatedly. Lipemic, hemolyticor bacterially contaminated samples can cause false positive or falsenegative results. For the performance of the test the samples (not thestandards) have to be diluted 1:101 with ready-to-use sample diluent (e.g. 5uL serum + 500 uL sample diluent).
Detection Method
I-ELISA
Sample
serum and plasma
Assay Procedure
1. ReagentAnd Sample Preparation WashingSolution: dilute before use1+9 with distilled water. If during the cold storage crystals precipitate, the concentrate should be warmed up at 37C for 15 minutes. 1) Strictadherence to the protocol is advised for reliable performance. Any changes ormodifications are the responsibility of the user. 2) Allreagents and samples must be brought to room temperature before use, butshould not be left at this temperature longer than necessary. 3)Standards and samples should be assayed in duplicates. 4) Astandard curve should be established with each assay. 5) Returnthe unused microtiter strips to the plastic bag and store them dry at 2-8oC. 2.Assay Steps 1) Preparea sufficient amount of microtiter wells for the standards, controls andsamples in duplicate as well as for a substrate blank. 2) Pipet100 uL each ofthe diluted (1:101) samples and the ready-to-use standards and controlsrespectively into the wells. Leave one well empty for the substrate blank. 3) Coverplate with the enclosed foil and incubate at room temperature for 60 minutes. 4) Emptythe wells of the plate (dump or aspirate) and add 300 uL ofdiluted washing solution. This procedure is repeated totally three times.Rests of the washing buffer are afterwards removed by gentle tapping of themicrotiter plate on a tissue cloth. 5) Pipet100 uL each ofready-to-use conjugate into the wells. Leave one well empty for the substrateblank. 6) Coverplate with the enclosed foil and incubate at room temperature for 30 minutes. 7) Emptythe wells of the plate (dump or aspirate) and add 300 uL ofdiluted washing solution. This procedure is repeated totally three times.Rests of the washing buffer are afterwards removed by gentle tapping of themicrotiter plate on a tissue cloth. 8) Pipet100 uL each ofthe ready-to-use substrate into the wells. This time also the substrate blankis pipetted. 9) Coverplate with the enclosed foil and incubate at room temperature for 20 minutesin the dark(e.g. drawer). 10) Toterminate the substrate reaction, pipet 100 uL each ofthe ready-to-use stop solution into the wells. Pipet also the substrateblank. 11) Afterthorough mixing and wiping the bottom of the plate, perform the reading ofthe absorption at 450 nm (optionally reference wavelength of 620 nm). Thecolor is stable for at least 60 minutes.
Evaluation
The meanvalues for the measured absorptions are calculated after subtraction of thesubstrate blank value. The difference between the single values should notexceed 10%. 1.Qualitative Evaluation Thecalculated absorptions for the patient sera, as mentioned above, are comparedwith the value for the cut-off standard. If the value of the sample ishigher, there is a positive result. For a value below the cut-off standard, there is a negative result. It seems reasonable to define a range of +/-20 %around the value of the cut-off as a grey zone. In such a case the repetitionof the test with the same serum or with a new sample of the same patient, taken after 2-4 weeks, is recommended. Both samples should be measured inparallel in the same run. The positive control must show at least the doubleabsorption compared with the cut-off standard. 2.Quantitative Evaluation Theready-to-use standards and controls of the Mumps antibody kit are defined andexpressed in arbitrary units (U/mL). This results in an exact and reproduciblequantitative evaluation. Consequently for a given patient follow-up controlsbecome possible. The values for controls and standards in units are printedon the labels of the vials. For a quantitative evaluation the absorptions ofthe standards and controls are graphically drawn against theirconcentrations. From the resulting reference curve the concentration valuesfor each patient sample can then be extracted in relation to their absorptions.It is also possible to use automatic computer programs.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 96T
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 30.08.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen